Dr. Priscilla Hsue is an international expert in the cardiovascular consequences of HIV infection and started her career by establishing an HIV cardiology clinic and is one of a few cardiologists around the world with both clinical and research expertise in this area. Her research interest is in the pathogenesis, clinical manifestations and treatment of cardiovascular disease and inflammation in HIV. As an investigator, Dr. Hsue leads a multidisciplinary team which encompasses a broad portfolio of clinical and translational studies on HIV-related cardiovascular disease. She has performed clinical trials of anti-inflammatory, immunomodulatory, and lipid lowering therapies in the setting of HIV, rheumatoid arthritis, atherosclerosis, and recently, COVID-19. Dr. Hsue has had continuous NIH funding since 2005 and is currently PI and Co-I on numerous NIH grants. She has published widely in the area of HIV-related cardiovascular disease and inflammation including publications in NEJM, Circulation, JACC, Jama Cardiology, Clinical Infectious Diseases, and AIDS. She has been Chair of the Clinical and Integrative Cardiovascular Science study section at NHLBI, a member of the Office of AIDS Research Advisory Council at NIH, and also a member of the Scientific Committee of the Sarnoff Cardiovascular Research Foundation. Currently, Dr. Hsue servesas Co-Director of the Center for Excellence in Vascular Research, is an elected member of the American Society of Clinical Investigation (and is the Secretary-Treasurer of this organization), and is also a member of the Association of University Cardiologists, ImmunoX, and CVRI.She has had the privilege of mentoring numerous students, residents, fellows, and faculty and has been recognized by multiple mentoring awards and grants.
Maurice Eliaser Jr MD Distinguished Professor of Medicine, University of California, San Francisco.
Chief of Cardiology, University of California, San Francisco, at Zuckerberg San Francisco General Hospital.
